4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,820.00
  • 52 Week Low: 1,070.80
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 1
  • Market Cap: £172.01m
  • Beta: 0.01

Latest ShareCast News

4basebio reports strong full-year progress

By Josh White

Date: Tuesday 27 May 2025

(Sharecast News) - 4basebio reported strong progress for the year ended 31 December on Tuesday, with revenue doubling from DNA sales to £0.93m and key operational milestones achieved.

4basebio's Cambridge facility gets GMP certification

By Josh White

Date: Wednesday 02 Apr 2025

(Sharecast News) - 4basebio announced on Wednesday that it has received Good Manufacturing Practice (GMP) certification from the UK's Medicines and Healthcare Products Regulatory Agency for its DNA manufacturing facility in Cambridge, marking a key milestone in its development as a supplier of clinical-grade synthetic DNA.

4basebio losses widen as it progresses commercial development

By Josh White

Date: Friday 27 Sep 2024

(Sharecast News) - 4basebio, a biotechnology company specialising in synthetic DNA products and nucleic acid delivery platforms, reported revenue of over £0.3m for the six months ended 30 June on Friday.

4basebio to provide synthetic DNA to tier-one ph... 10-Apr-2024 ShareCast
4basebio client gets approval to start trial in ... 21-Mar-2024 ShareCast
4basebio inks significant DNA supply contract 01-Mar-2024 ShareCast
First-half losses narrow for 4basebio 21-Sep-2023 ShareCast
4basebio inks supply deal with Italy's Neomatrix 25-May-2023 ShareCast
4basebio enters neurofibromatosis collaboration ... 10-Jun-2022 ShareCast
Losses to continue as 4basebio focuses on commer... 09-May-2022 ShareCast
4basebio inks development deal with Heqet Therap... 27-Apr-2022 ShareCast
4basebio launches two new synthetic DNA products 23-Mar-2022 ShareCast
4basebio makes progress with manufacturing devel... 15-Feb-2022 ShareCast
4basebio enters research collaboration with eThe... 18-Jan-2022 ShareCast
4basebio enters development deal with T-cell the... 23-Nov-2021 ShareCast
4basebio files for patent on novel DNA type 22-Jun-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,820.00
52 Week Low 1,070.80
Volume 1
Shares Issued 15.50m
Market Cap £172.01m
Beta 0.01

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.4% below the market average67.4% below the market average67.4% below the market average67.4% below the market average67.4% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
4.64% below the market average4.64% below the market average4.64% below the market average4.64% below the market average4.64% below the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Income Not Available
Growth
56.88% above the market average56.88% above the market average56.88% above the market average56.88% above the market average56.88% above the market average
61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average

4basebio Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
11:30 1 @ 1,070.80p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page